Abstract
Small interfering RNA (siRNA) is a promising tool for gene therapy-based disease treatments. However, delivery of siRNA to the target cells requires a specific and reliable carrier system. Herein we describe a targeted carrier system that can deliver siRNA to cancer cells overexpressing the human epidermal growth factor 2 (HER2) receptor. Trastuzumab-conjugated poly(amido)amine dendrimers can be synthesized using the protocols described here.
| Original language | English |
|---|---|
| Title of host publication | Methods in Molecular Biology |
| Publisher | Humana Press Inc. |
| Pages | 195-201 |
| Number of pages | 7 |
| DOIs | |
| State | Published - 2019 |
Publication series
| Name | Methods in Molecular Biology |
|---|---|
| Volume | 1974 |
| ISSN (Print) | 1064-3745 |
| ISSN (Electronic) | 1940-6029 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bioconjugation
- Dendrimers
- HER2 receptors
- siRNA delivery
- Trastuzumab
Fingerprint
Dive into the research topics of 'Monoclonal antibody-conjugated dendritic nanostructures for siRNA delivery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver